FDA Extends the Public Comment Period for the Comprehensive, Multi-Year Nutrition Innovation Strategy
August 16, 2018
The U.S. Food and Drug Administration is extending the public comment period for the agency’s Nutrition Innovation Strategy by 45 days. The docket will now remain open until October 11, 2018. The comment period for the notice of public meeting and request for comments published in the Federal Register on June 27, 2018.
FDA is extending the comment period in response to numerous stakeholder requests for additional time and an opportunity to review the public meeting materials. FDA will post materials from the July 26, 2018 Nutrition Innovation Strategy public meeting to provide more information to those wishing to comment on the open docket. The additional materials will include speaker presentation slides, breakout session summary notes, and the meeting transcript.
To submit comments to the docket by mail, use the following address.
Dockets Management Staff (HFA-305)
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852
Please be sure to include docket number FDA-2018-N-2381 on each page of your written comments.
For Additional Information